iifl-logo-icon 1

Brooks Laboratories Ltd Share Price

82.38
(-2.83%)
Jul 15, 2024|03:32:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open85.01
  • Day's High85.02
  • 52 Wk High185.7
  • Prev. Close84.78
  • Day's Low82
  • 52 Wk Low73.25
  • Turnover (lac)28.59
  • P/E145.84
  • Face Value10
  • Book Value26.63
  • EPS0.58
  • Mkt. Cap (Cr.)216.22
  • Div. Yield0
No Records Found

Brooks Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

85.01

Prev. Close

84.78

Turnover(Lac.)

28.59

Day's High

85.02

Day's Low

82

52 Week's High

185.7

52 Week's Low

73.25

Book Value

26.63

Face Value

10

Mkt Cap (₹ Cr.)

216.22

P/E

145.84

EPS

0.58

Divi. Yield

0

Brooks Laboratories Ltd Corporate Action

12 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

30 Aug 2023

12:00 AM

AGM

Announcement Date: 30 Aug, 2023

arrow

18 Jul 2023

12:00 AM

Rights

arrow

30 Aug 2023

12:00 AM

BookCloser

arrow

Brooks Laboratories Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Brooks Laboratories Ltd SHAREHOLDING SNAPSHOT

15 Jul, 2024|03:23 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 63.59%

Foreign: 0.00%

Indian: 63.59%

Non-Promoter- 3.86%

Institutions: 3.86%

Non-Institutions: 32.54%

Custodian: 0.00%

Share Price

Brooks Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

24.7

24.7

24.7

24.7

Preference Capital

0

0

0

0

Reserves

32.08

40.3

39.51

73.71

Net Worth

56.78

65

64.21

98.41

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

77.24

69.68

55.71

57.53

yoy growth (%)

10.84

25.08

-3.17

-28.08

Raw materials

-47.47

-46.82

-39.37

-36.66

As % of sales

61.45

67.19

70.67

63.71

Employee costs

-14.36

-13.38

-11.8

-8.25

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-8.43

-13.51

-17.53

2.48

Depreciation

-7.09

-6.64

-6.44

-1.67

Tax paid

-7.15

-10.86

3.72

-0.81

Working capital

-1.12

6.26

0.96

-6.78

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

10.84

25.08

-3.17

-28.08

Op profit growth

-119.47

-55.87

-276.31

-54.51

EBIT growth

-47.44

-32.66

-532.2

-69.59

Net profit growth

-36.05

76.47

-928.65

-84.32

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

79.49

63.2

91.08

77.25

Excise Duty

0

0

0

0

Net Sales

79.49

63.2

91.08

77.25

Other Operating Income

0

0

0

0

Other Income

0.96

0.57

0.91

0.74

Brooks Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,577.3

124.083,78,675.04867.60.865,536.9998.75

Cipla Ltd

CIPLA

1,512.05

32.871,22,092.681,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,539.3

76.441,20,480.265310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,175.15

34.281,18,217.41,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,719.45

26.171,12,137.091,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Brooks Laboratories Ltd

Management

Register Office

Registrar Office

Independent Director

Rajnish Kumar Bedi

Independent Director

Deepak Mahajan

Independent Director

Sonia Gupta

Whole Time Director

Jitendra Pratap Singh

Whole-time Director

Durga Sankar Maity

Whole-time Director

Mr. Bhushan Singh Rana

Company Sec. & Compli. Officer

JAI PRAKASH VAIDYA

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Brooks Laboratories Limited was incorporated on January 23, 2002. The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis. The company has manufacturing plants at Baddi, Himachal Pradesh and Vadodara, Gujarat. Both the units are cGMP compliant in conformity with national and international standards. The Vadodara facility of the company has been approved by European Medicine agency. The company has a wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc. Their product portfolio presently comprises of 28 Injectables, 19 Tablets and 2 Dry Syrups which are marketed domestically.The companys manufacturing facilities are designed to manufacture a variety of products in the formulation segment using a combination of processes. At Baddi, they manufacture wide range of products under the formulation segment for various top notch companies of India.The companys major clients are companies like Zydus Cadila, Aristo Pharmaceuticals Pvt Ltd, FDC Ltd, Nectar Lifesciences Ltd, Sanat Products Ltd, Hetero Healthcare Ltd, Medley Pharmaceuticals, Wockhardt Ltd, Parental Drugs, Chanderbhagat Pharma and Alembic Ltd etc. Their major suppliers of raw materials are Rajasthan Antibiotics Ltd, A
Read More

Company FAQs

What is the Brooks Laboratories Ltd share price today?

Down Arrow

The Brooks Laboratories Ltd shares price on N/A is Rs.₹82.3 today.

What is the Market Cap of Brooks Laboratories Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Brooks Laboratories Ltd is ₹216.01 Cr. as of 15 Jul ‘24

What is the PE and PB ratio of Brooks Laboratories Ltd?

Down Arrow

The PE and PB ratios of Brooks Laboratories Ltd is 145.84 and 3.19 as of 15 Jul ‘24

What is the 52 Week High and Low of Brooks Laboratories Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Brooks Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Brooks Laboratories Ltd is ₹72.51 and ₹185.15 as of 15 Jul ‘24

What is the CAGR of Brooks Laboratories Ltd?

Down Arrow

Brooks Laboratories Ltd's CAGR for 5 Years at 19.47%, 3 Years at -2.73%, 1 Year at 11.86%, 6 Month at -50.66%, 3 Month at -20.91% and 1 Month at 0.77%.

What is the shareholding pattern of Brooks Laboratories Ltd?

Down Arrow

The shareholding pattern of Brooks Laboratories Ltd is as follows:
Promoters - 63.59 %
Institutions - 3.86 %
Public - 32.55 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.